AMRX•benzinga•
Drug Maker Amneal Highlights Strong Commercial Uptake For Parkinson's Drug But Q1 Earnings Are Mixed
Summary
Amneal Pharmaceuticals reported first-quarter 2025 adjusted earnings per share of 21 cents, up from 14 cents a year ago.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 2, 2025 by benzinga